Planned study - Immunoglobulins (Ig) are administered to patients with immune disorders, autoimmune diseases and certain neurological diseases to prevent infections or to slow down or support the immune system.
This study will focus primarily on the demand for immunoglobulins (Ig), providing a detailed analysis of their use in Belgium. The assessment will cover both use in reimbursed indications and off-label use, in order to better understand for which patients and in which indications these blood products are most frequently used. A comparison with other countries will be carried out and trends will be analysed
The potential added value of describing current monitoring mechanisms and their shortcomings in comparison with other countries will be assessed after the start of the project. Work already available on this subject within the framework of the European SUPPLY project will be taken into consideration.
- Study 2026-70 (Method) A framework for ethics in screening programs
- Study 2026-13 (GCP) Update of the clinical practice guideline for the management of low back pain
- Study 2026-50 (HSR) Improving forensic care in Belgium
- Study 2026-43 (EVAL) Evaluation of the implementation process and impact of the ‘integrated care pathway for patients suffering from persistent functional disorders related to exhaustion’ (post-viral syndrome)
- Study 2026-41 (EVAL) Development and implementation of the evaluation of the implementation process and impact of the programme on obesity in children and adolescents
